Futuristic Advancements: Viscosupplementation Market to Surge and Cross the USD 2.89 Billion Mark by 2030, States FMI

Joint pain is a common ailment affecting millions of people worldwide. It can significantly impact the quality of life, limiting mobility and causing discomfort. However, thanks to advancements in medical technology, there’s a revolutionary treatment option available called Viscosupplementation Market. This innovative approach has gained considerable attention in recent years and is transforming the way we manage joint pain.

Viscosupplementation involves the injection of hyaluronic acid (HA) into the affected joint to alleviate pain and improve joint function. Hyaluronic acid is a naturally occurring substance found in the synovial fluid, which provides lubrication and cushioning to the joints. In individuals with osteoarthritis, the concentration of HA decreases, leading to joint deterioration and pain.

Grab Your Exclusive Report: Unveiling the Spectacular Growth of the Viscosupplementation Market @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9509

By 2022, it is anticipated that the viscosupplementation equipment market would be worth US$ 1.98 billion. The global viscosupplementation market is predicted to grow at a CAGR of 4.8% from current levels to reach a market size of US$ 2.89 billion by 2030, based on thorough market research.

This market, which has been relatively less affected by COVID-19-induced sluggishness, will increase as a result of a combination of general and industry-specific causes, the report claims. The UN predicts that by 2050, people 60 and older will make up more than 20% of the world’s population. In other words, the UN estimates that 130 million people will have osteoarthritis by 2050. These numbers suggest that during the projection period, the viscosupplementation market will grow.

Top Key Players Covered-

• Sanofi S.A.
• Zimmer Biomet Holdings Inc.
• Bioventus LLC
• Anika Therapeutics Inc.
• Fidia Farmaceutici S.p.A.
• Ferring B.V.
• Seikagaku Corporation
• Chugai Pharmaceutical Co., Ltd.
• OrthogenRx Inc.
• Mylan N.V.

Don’t hesitate to get in touch with our analyst if you need clarification @ https://www.futuremarketinsights.com/ask-question/rep-gb-9509

Key Takeaways of Viscosupplementation Market Study

• Three injection viscosuppplementation is expected to contribute for more than 55% of revenue share
• Knee osteoarthritis is expected to gain around one-third of market share during the forecast period
• North America is the highest revenue generating market due to scientific advancements and high adoption of viscosuppplementation

New Product Development to be the TorchbearerThe market players are into the innovation mode to strengthen their foothold in the viscosupplementation market. This competitive landscape is all set to create ripples all across the market. Some of the innovations are:

• Fidia Pharma USA Inc., in 2019, introduced a HA (Hyaluronic Acid) based intra-articular viscosupplement called “TRILURON” to treat knee osteoarthritis. The treatments cycle involves 3 injections at weekly intervals.
• Japan-based Seikagaku Corporation, in Mar 2019, launched an intra-articular single-injection viscosupplement called “HyLink” in Italy for treating knee osteoarthritis.
• Recently, Gel-One Hyaluronate was approved as one of the injectable gels to treat osteoarthritis of knee. The pre-market clinical study reported no pseudosepsis (severe acute inflammatory responses).

Customize Your Knowledge: Unlock Targeted Insights to Drive Growth in the Viscosupplementation Market @ https://www.futuremarketinsights.com/customization-available/rep-gb-9509

Key Segments of Viscosupplementation Industry Survey

Viscosupplementation Market by Product:

• Single Injection Viscosupplementation
• Three Injection Viscosupplementation
• Five Injection Viscosupplementation

Viscosupplementation Market by Application:

• Knee Osteoarthritis
• Hip Osteoarthritis
• Shoulder Osteoarthritis
• Others

Viscosupplementation Market by End User:

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Retail Pharmacies
• Online Sales

Gain Immediate Access to Detailed Market Insights: Purchase Now @ https://www.futuremarketinsights.com/checkout/9509

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 09-years.

Contact Us:           

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube